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Background and Aims: PainData is an electronic internet-based clinical pain registry 
established to improve the understanding and treatment of high-impact chronic pain. The 
primary aim of this paper is to describe socio-demographics, pain characteristics, quality of 
life, and treatment values at baseline and follow-up in individuals referred to public and 
private interdisciplinary pain centers in Denmark between 2018 and 2020.
Methods: Self-reported patient-reported outcomes collected through PainData before 
(n=12,257) and after (n=4,111) treatment across 13 public and private interdisciplinary 
specialized pain centers in Denmark (87% of all pain centers in Denmark) are described.
Results: Mean duration of pain was 10 years, and one in three patients reported chronic 
widespread pain. More than 40% reported opioid use, and 50% had tried four or more different 
treatment modalities prior to referral. More than 60% reported poor sleep, severe fatigue, and 
memory and/or concentration deficits. Mean scores on pain catastrophizing, fear of movement, 
and pain-related disability were high, whereas scores on pain acceptance and self-efficacy were 
low. Physical and mental health were rated as poor and fair, respectively. One in four patients 
reported being very much improved or much improved after treatment. Items commonly reported 
after treatment were increased knowledge about pain, emotions and mood (66.5%), being better 
at accepting life with chronic pain (63.1%), and improved activity pacing (60.6%).
Conclusion: The PainData registry, containing data from a large cohort of individuals, can 
help to improve the understanding and treatment of high-impact chronic pain, and collabora-
tions with other researchers are welcome.
Keywords: chronic pain, registry, PainData, questionnaires
Introduction
Chronic pain, as recognized by the International Association for the Study of Pain 
(IASP) as pain that persists past normal healing time,1 is one of the leading causes 
of disability in the western world,2 and it is associated with high rates of opioid 
consumption,3 healthcare utilization,4 depression and anxiety,5 as well as exclusion 
from the workforce.6 Similarly to many other countries, chronic pain in Denmark is 
a costly health problem, with an estimated annual expenditure for low back pain 
alone of over $1 billion dollars in 2015.7
The majority of individuals with chronic pain are treated in the primary care 
sector, for example by their general practitioner, a physiotherapist, or a chiropractor, 
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with a smaller part attending hospital departments (eg, 
rheumatology or neurology) in secondary care. For indivi-
duals who do not benefit from primary or secondary care 
treatments, clinical guidelines recommend referral to inter-
disciplinary pain management programs in tertiary care 
settings.8,9 Based on recent data from the USA, approxi-
mately 8% of the population report high-impact chronic 
pain, defined as persistent pain with substantial restriction 
of life activities lasting 6 months or more,10 indicating that 
more than 350,000 Danes above 18 years of age may need 
treatment in a specialist interdisciplinary pain center.11
Across a range of health conditions, including chronic 
pain,12,13 large-scale clinical registries are established to 
provide a data resource for quality assurance and research 
to inform clinical decision making and health policy.14,15 
PainData is a clinical pain registry that aims to improve 
the understanding and treatment of individuals experien-
cing high-impact chronic pain. This involves the collection 
of patient-reported outcome (PRO) data from individuals 
referred to one of the public or private pain centers that 
offer specialized interdisciplinary pain treatment in 
Denmark. The collection of PRO data in the registry has 
three main aims: 1) to serve as a clinical tool to facilitate 
the dialogue between the individual and the interdisciplin-
ary team during consultations, 2) to serve as a tool for 
national benchmarking and quality assurance, and 3) to 
facilitate national and international research in the field of 
high-impact chronic pain. PainData was developed and 
first implemented at the Pain Center at Odense 
University Hospital (Smertecenter Syd) in 2015. At that 
time, there was no equivalent national pain registry, and 
that is still the case. In 2018, the Danish Regions, which is 
the association and interest organization for the five 
regions in Denmark, launched a series of projects on 
value-based healthcare (Værdibaseret Sundhed [VBS]),16 
including a project focusing on VBS within interdisciplin-
ary pain treatment. A series of workshops were hosted to 
progress the outcome evaluation and benchmarking 
agenda according to what gives the greatest value and 
effect for the individual patient. In each workshop, there 
was representation from many different stakeholders, 
including the Danish Pain Society, the Danish 
Rheumatology Association, the Association of Chronic 
Pain Patients, the Fibromyalgia Association, the 
Association of General Practitioners, the Danish 
Psychology Association, leaders from public and private 
pain centers, as well as representatives from different 
interdisciplinary professions (social workers, 
physiotherapists, pain physicians, nurses, and psycholo-
gists). The major outcomes of the workshops were 1) to 
explore patient values and goals in relation to interdisci-
plinary pain treatment, 2) to develop and test a battery of 
questions to assess the patient’s values and goals, and 3) to 
agree on a minimum core data set, which would give 
insights into the patient’s situation while reducing the 
burden of the patient, and allow for meaningful compar-
isons between centers. By June 1st 2019, questions related 
to patients’ values and goals were developed and subse-
quently implemented in PainData in 10 out of 11 public 
interdisciplinary pain centers in Denmark, as well as in 
four out of five private interdisciplinary pain centers in 
Denmark, along with the Patient-Reported Outcomes 
Measurement Information System (PROMIS) Scale 
v1.2 – Global Health. The aims of this paper are to 
introduce the PainData registry and to summarize the self- 
reported characteristics of individuals with high-impact 
chronic pain who had an initial consultation, as well as 
the characteristics of individuals who completed treatment 
in a public or private interdisciplinary pain center in 
Denmark from 2018 to 2020.
Methods
Design
The included data are taken from an observational study of 
individuals who had their initial consultation or indivi-
duals who completed treatment in a public or private 
interdisciplinary pain center in Denmark between 
January 1st 2018 and December 31st 2020. Reporting of 
the study follows the STROBE guidelines (STrengthening 
the Reporting of OBservational studies in 
Epidemiology).17
Study Population
Participants are Danish individuals with chronic pain 
registered in the PainData registry at one of the following 
interdisciplinary pain centers: 1) Pain Center, University 
Hospital Odense; 2) Interdisciplinary Pain Center 
University Hospital Aalborg; 3) Pain Clinic, Regional 
Hospital Silkeborg; 4) Interdisciplinary Pain Center 
University Hospital Køge; 5) Interdisciplinary Pain 
Center Næstved Hospital; 6) Interdisciplinary Pain 
Center Holbæk Hospital; 7) Interdisciplinary Pain Center 
Gentofte Hospital; 8) Interdisciplinary Pain Center 
Rigshospitalet; 9) Pain Clinic, Friklinikken, Grindsted; 
10) Interdisciplinary Pain Center, Lillebaelt Hospital; 11) 
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Interdisciplinary Pain Center Allévia; 12) CFR Capio, 
Skørping; or 13) The Private Pain Clinic, Herlev. Pain 
centers/clinics 1–10 are public hospitals, and clinics 11– 
13 are private pain clinics with public funding. All inter-
disciplinary pain centers using PainData are outpatient 
hospital settings treating patients with chronic (>6 months) 
non-cancer pain conditions. Patients referred to the pain 
centers have previously tried a number of treatments in 
primary and secondary care settings with an unsatisfactory 
clinical response. Treatments across the different pain 
centers can be diverse, but commonly consist of one or 
more of the following elements: medical treatment with 
a specialist pain consultant (ie, individual adjustment of 
analgesics to improve effects and reduce side effects), 
individual consultations with a pain psychologist, phy-
siotherapist, or social worker with cognitive–behavioral 
therapy training, participation in group sessions with 
relaxation therapy, acceptance and commitment therapy, 
or mindfulness-based stress reduction programs, which 
have shown moderate effects in this population.
Inclusion and Exclusion Criteria
Individuals with chronic pain,1 who were scheduled for an 
initial consultation, completed the baseline questionnaire 
and gave data consent, or individuals who had completed 
treatment and completed the follow-up questionnaire and 
gave data consent in one of the involved public or private 
interdisciplinary pain centers in Denmark between 
January 1st 2018 and December 31st 2020, were included 
in the study.
The PainData Registry
The patient part of the PainData registry (see https://pain 
data-test.rsyd.dk) is designed to capture PRO data at dif-
ferent time points related to the clinical contact in one of 
the interdisciplinary pain centers. Patients can access the 
registry 24 hours per day, 7 days per week, via different 
web browsers. After referral to a pain center but before the 
initial consultation, all referred patients are invited to 
answer questions about their clinical pain characteristics 
and adaptations to pain through a web-based questionnaire 
system sent via a personal link to the patients’ official 
inbox, e-Boks (the channel that the Danish State and 
municipalities use to send official documents to citizens). 
Questionnaires are completed at home before the first 
consultation. None of the questions are mandatory. In 
addition to basic demographics, data include question-
naires for measures of pain intensity, disability, physical 
and mental health, quality of life, several psychological 
constructs, and patient values in relation to treatment. 
During completion of the questionnaires, patients are 
invited to give consent so that the questionnaire data can 
be stored in the PainData research database and used for 
later research. The Danish Data Protection Agency 
approved the data collection (18/35221). The collected 
data are protected in accordance with the “Act on the 
Processing of Personal Data” (Act No. 429 of 31/05/ 
2000) and the “Law on the Status of Patients’ (Act No. 
482 of 01/07/1998). Participants’ personal data are pro-
tected in accordance with the Personal Data Processing 
Act and the Health Act. The duration of data retention is in 
accordance with notification to the Danish Data 
Inspectorate. The PainData registry runs on servers mana-
ged by the governmental administration of the Region of 
Southern Denmark. In addition to pain-related question-
naires at baseline and after treatment, PRO data are col-
lected 12, 24, 36, 48, and 60 months after completed 
treatment, if patients consent to being contacted, to estab-
lish a unique prospective cohort over time. As several of 
the centers/clinics that use PainData have not been collect-
ing data for more than 1–2 years, we only report data from 
baseline and immediately after treatment in this paper.
In the clinician part of the PainData registry, 
a summary report from each individual patient’s self- 
reported questionnaire is generated, so that the inter-
disciplinary team can see the report before seeing the 
patient during the consultations. All information pro-
cessing is in real time so that summary data are 
instantly available to the interdisciplinary team. The 
registry also has the possibility for clinicians to enter 
information (eg, pain diagnosis, comorbidities, or 
planned treatment); however, a consensus between the 
involved clinics on collection of clinician data has not 
yet been reached.
The PainData registry was developed by the Pain 
Center, University Hospital Odense, with the support of 
the Department of Anaesthesiology and Intensive Care 
Medicine, University Hospital Odense. The ongoing main-
tenance costs are divided evenly between the involved 
pain centers/clinics based on a cooperation agreement. 
The registry has been built to meet all current Danish 
health data security standards for data access, storage, 
back-up, and the tracking of who accesses, inputs, or 
modifies data. This is achieved via login requirements, 
passwords, two-factor authentication, firewalls, and log-
ging of access.
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Baseline and Follow-Up Questionnaires
Based on the biopsychosocial model of pain,18 PRO data 
are collected across several biopsychosocial domains, 
including pain, disability, work participation, psychologi-
cal factors, quality of life, contextual factors, and patient 
values. Wherever possible, the choice of questions and 
questionnaires was based on recommendations and evi-
dence of their role in chronic pain.19–21 The 35 questions 
in the minimum core data set include sex, age, height, 
weight, education, and work situation, as well as items 
related to manifestations of pain: pain chart (any locations 
of pain during the previous week [Figure 1A], which are 
used in other clinical registries in Denmark22), onset date 
of pain, pain intensity (worst, average, and least in the last 
24 hours, using numeric rating scales [NRSs] ranging from 
0 [no pain] to 10 [worst imaginable pain],23 and the 
average during the last 7 days item from the PROMIS-10 
Global Health24), use of analgesics (type, brand, dose, 
frequency), analgesic effect in the last 24 hours, screening 
for 1) sleep disturbance using the four items adapted from 
the Karolinska Sleep Questionnaire (KSQ) sleep quality 
subscale, assessing frequency of sleep disturbance, fre-
quency of early awakenings, frequency of difficulties fall-
ing asleep and frequency of night-time awakenings with 
difficulty returning to sleep,25 2) stress, pain catastrophiz-
ing, and fear of movement using three-item screening 
questions,26 and 3) general health, physical and mental 
health, social activities, and fatigue using the PROMIS- 
10 Global Health.24 Items related to patient values in 
relation to treatment were based on workshops in the 
value-based healthcare project (see Table 3).
When the treatment course has been completed, 
patients are invited to complete a follow-up questionnaire, 
which contain approximately two-thirds of the questions in 
the baseline questionnaire. Further details about the ques-
tionnaires in the additional larger data set used by the 10 
public pain centers/clinics are provided in Supplementary 
Table S1.
Statistical Analysis
Descriptive statistics (mean and standard deviation [SD], 
median and percentiles) were used to describe socio- 
demographic status, pain characteristics, psychological 
distress, quality of life, and responses to value-based 
healthcare items at baseline and follow-up for women 
and for men. As the aim of this paper was not to compare 
PRO measures between men and women but to describe 
the population in the registry, no sex-related hypotheses 
were established a priori, and thus no formal statistical 
tests were performed. For the purpose of the description, 
the duration of pain was also grouped into less than 1 year, 
1–3 years, 3–5 years, 5–10 years, and more than 10 years. 
The variable on education was grouped into the following 
categories: “Primary school education”, “Upper secondary 
education”, “Vocational education and training”, “Short 
cycle higher education”, “Vocational bachelor education”, 
and “Master’s program”. Baseline differences between 
responders and non-responders to the follow-up question-
naire were analyzed with independent t-tests or χ2 tests, 
where appropriate. Differences in PRO measures at base-
line and follow-up for patients who started and completed 
treatment within the period 2018–2020, who completed 
Figure 1 Spatial pain distribution. (A) Body chart from a patient questionnaire; (B) body chart divided into 71 body areas with the pain drawing distributed across 16 body 
areas; (C) body chart divided into seven body regions with the pain drawing distributed across four body regions.
https://doi.org/10.2147/JPR.S306504                                                                                                                                                                                                                                   
DovePress                                                                                                                                                               
Journal of Pain Research 2021:14 1218
Vaegter et al                                                                                                                                                          Dovepress
both questionnaires and gave data consent, are presented 
with 95% CI, and effect sizes were calculated as Cohen’s 
d, with d=0.2 reflecting a small, d=0.5 a medium, and 
d=0.8 a large effect.27 All statistical tests were two tailed 
and the level of significance was set at p<0.05.
Results
Baseline Characteristics
In all, 17,351 patients were registered in PainData, with an 
initial consultation date in a public or private interdisci-
plinary pain center in Denmark between January 1st 2018 
and December 31st 2020. How many of these patients 
showed up for their initial consultation is not registered 
in the database. The baseline questionnaire completion rate 
was 76.6% (n=13,291) of all registered patients. The con-
sent rate for the use of personal questionnaire data for 
quality assurance and research use among completers of 
the baseline questionnaire was 92.3%. In total, 12,257 
patients completed the baseline questionnaire and gave 
data consent. The amount of missing data on individual 
questions among these patients was relatively low (Table 
1). Characteristics of the population at baseline in the 13 
interdisciplinary pain centers/clinics are illustrated in 
Table 1 for women and for men. Percentiles for each 
variable are illustrated in Table 2 for women and for 
men. Responses to value-based healthcare questions are 
illustrated in Table 3.
Socio-Demographics
The mean age of all individuals was 50.0±14.6 years 
(range 18–99 years) (Table 1). In total, 67.9% of patients 
in the registry were women. More than 30% of the indi-
viduals had vocational education and training as the high-
est level of education (higher proportion of men) and less 
than 5% had an educational level equivalent to a master’s 
program. Almost 30% of individuals were on a pension, 
and 20% of patients not on a pension were on sick leave.
Pain Characteristics
The mean duration since the pain debut was 10.0 years 
(range 0.25–84 years). On average, the peak pain intensity 
level during the last 24 hours corresponded to moderately 
severe pain (~7.8 out of 10) (Table 1). Of all the indivi-
duals, back pain, followed by pain in the thorax/abdomen/ 
genital area within the past week were reported most 
frequently (Table 1). Based on the body drawing illu-
strated in Figure 1B, the mean number of painful body 
areas was 21.6, and the median number of painful body 
regions was 5 (Figure 1C). Based on the American College 
of Rheumatology’s definition of chronic widespread pain 
(CWP) as pain localized in both the right and left sides of 
the body, both above and below the waist plus in the axial 
skeleton,28 30.9% of patients had CWP. Almost 90% 
reported using analgesics, with 43% reporting opioid use. 
Most patients reported that several different treatment 
modalities had previously been tried to relieve the pain, 
with more than 40% reporting having had surgery. The 
most common non-invasive treatments were exercise, 
massage, and acupuncture. More than 50% had tried four 
or more different treatment modalities prior to referral to 
an interdisciplinary pain center/clinic.
Psychological Distress and Quality of Life
In general, mean scores on pain catastrophizing, fear of 
movement, and pain-related disability were high, whereas 
scores on pain acceptance and self-efficacy were low 
(Table 1). However, mean scores on depression and anxi-
ety were low to moderate. Physical and mental health 
assessed with the PROMIS Scale v1.2 – Global Health 
averaged 33.7 and 38.3 (T-scores), respectively, corre-
sponding to a classification of poor and fair physical and 
mental health, respectively (Table 1). More than 40% 
reported emotional problems often or always during the 
last 7 days.
Other Symptoms
More than 80% of all individuals reported disturbed sleep 
several times per week or more. Sixty percent reported 
severe or very severe fatigue during the last 7 days, and 
moderate to severe memory and/or concentration deficits 
were reported by almost 70% of the individuals.
Value-Based Healthcare Items
Since the implementation of the value-based items in 
2019, the items that most individuals reported being of 
value to them in relation to treatment (scores from “to 
a moderate degree” to “to a very great degree”) were 
“being able to participate in social activities” (93.9%), 
“improved activity pacing” (89.6%), and “help to learn 
pain coping strategies” (83.8%). The items that fewest 
individuals reported being of value to them (scores from 
“to a moderate degree” to “to a very great degree”) were 
“help with work and income” (58.3%), “improved com-
munication about living with chronic pain” (69.3%), and 
“gain knowledge about pain, emotions and mood” (75.5%) 
(Table 3).
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Table 1 Characteristics (Mean ± Standard Deviation and Range or Proportions) of Individuals Who Had an Initial Consultation (Baseline) 
and Individuals Who Completed Treatment (Follow-Up) in a Public or Private Interdisciplinary Pain Center in Denmark from 2018 to 2020.
Variables in the Minimum Core Data Set Baseline (n=12,257) Follow-Up (n=4111)
Women (n=8324; 
67.9%)
Men (n=3933) Women 
(n=2765; 67.3%)
Men (n=1346)
Age (years), M±SD (range), n=12,257 (missing=0.0%) 49.1±14.7 (18–99) 51.9±14.3 (18–93) 51.5±14.3 (18–97) 55.0±13.5 (20–89)
Height (cm), M±SD (range), n=11,551 (missing=5.8%) 166.9±6.6 (130–198) 179.7±7.2 (152–210)
Weight (kg), M±SD (range), n=11,396 (missing=7.0%) 78.5±19.2 (35–185) 91.8±19.1 (42–200)
BMI (kg/m2), M±SD (range) 28.2±6.6 (12.9–70.8) 28.4±5.5 (13.6–50.1)
Highest education, n=11,531 (missing=5.9%)
Primary school education (%) 18.6 20.4
Upper secondary education (%) 6.2 4.9
Vocational education and training (%) 26.1 40.9
Short cycle education (%) 13.2 7
Vocational bachelor education (%) 25 14.6
Master’s program (%) 4.2 5
Others (%) 6.7 7.2
Work situation, n=11,436 (missing=6.7%)
Normal working hours (%) 11.4 13.2
Reduced working hours (%) 10.5 9.4
Sick leave (part time or full time) (%) 18.7 20.9
Pension (%) 27.8 31.3
Studying (%) 3.7 1.9
Unemployed (%) 4.9 4.4
Public welfare support (other than sick leave and 
unemployed) (%)
23 18.9
Pain duration (years), mean +/- SD (range), n=11,586 
(missing=5.5%)
10.3±10.2 (0.25–84) 9.5±10.3 (0.25–68.4)
<1 year (%) 5.7 7.9
1–3 years (%) 21.9 24.6
3–5 years (%) 14.2 14.6
5–10 years (%) 20.2 19.1
>10 years (%) 38 33.8
Peak pain intensity last 24 hours (NRS: 0–10), M±SD 
(range), higher is worse, n=11,728 (missing=4.3%)
7.8±1.6 (0–10) 7.8±1.6 (0–10) 6.9±2.1 (0–10) 7.0±2.2 (0–10)
Average pain intensity last 24 hours (NRS: 0–10), M 
±SD (range), higher is worse, n=11,703 (missing=4.5%)
6.5±1.8 (0–10) 6.5±1.9 (0–10) 5.8±2.1 (0–10) 5.8±2.2 (0–10)
Least pain intensity last 24 hours (NRS: 0–10), M±SD 
(range), higher is worse, n=11,645 (missing=5.0%)
4.8±2.3 (0–10) 4.8±2.4 (0–10) 4.3±2.4 (0–10) 4.4±2.5 (0–10)
Average pain intensity last 7 days (NRS: 0–10), M±SD 
(range), higher is worse, n=9,291 (missing=6.6%)
5.1±2.9 (1–10) 5.1±2.9 (0–10) 4.9±2.4 (0–10) 4.8±2.5 (0–10)
Pain areas (0–71), M±SD (range), higher is worse, 
n=11,833 (missing=3.5%)
23.7±16.7 (0–71) 17.2±13.4 (0–71)
Painful body areas (0–7), M±SD (range) 4.8±2.0 (0–7) 4.0±2.0 (0–7)
Head and neck pain (%) 68.6 55.2
Back pain (%) 79.8 77.8
Thorax/abdominal/genital pain (%) 72.3 59.6
Right leg pain (%) 67 56.5
Left leg pain (%) 67.2 59.1
Right arm pain (%) 64.5 47.4
Left arm pain (%) 63.1 48
(Continued)
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Table 1 (Continued). 
Variables in the Minimum Core Data Set Baseline (n=12,257) Follow-Up (n=4111)
Women (n=8324; 
67.9%)
Men (n=3933) Women 
(n=2765; 67.3%)
Men (n=1346)
Analgesic use (%), n=11,763 (missing=4.0%) 88.1 89.6 79.8 80.7
Opioids (%) 39.1 51 24 33.2
Tricyclic antidepressant (%) 19.9 18 22.8 19.7
Anticonvulsants (%) 23.3 27 24.6 27.1
NSAIDs (%) 28.8 25.7 15.2 14.1
Paracetamol (%) 71.5 64.5 48.3 42.4
Muscle relaxants (%) 15.8 14.3 21.9 17.5
Analgesic effect (effect in %), n=11,763 (missing=4.0%) 37.6±23.3 (0–100) 38.1±23.6 (0–100) 44.9±24.3 (0–100) 41.9±24.2 (0–100)
Stress (NRS: 0–10)*, M±SD (range), higher is worse, 
n=11,600 (missing=5.4%)
4.8±3.2 (0–10 4.6±3.2 (0–10) 4.2±2.9 (0–10) 4.3±3.1 (0–10)
Pain catastrophizing (NRS: 0–10)*, M±SD (range), 
higher is worse, n=11,591 (missing=5.4%)
6.9±2.7 (0–10) 7.2±2.7 (0–10) 5.4±3.0 (0–10) 5.9±2.9 (0–10)
Fear of movement (NRS: 0–10)*, M±SD (range), higher 
is worse, n=11,368 (missing=7.3%)
5.1±3.4 (0–10) 5.8±3.4 (0–10) 3.9±3.4 (0–10) 5.0±3.6 (0–10)
PROMIS-10 Physical Health, M±SD (range), higher is 
better, n=9291 (missing=6.6%)






PROMIS-10 Mental Health, M±SD (range), higher is 
better, n=9291 (missing=6.6%)




General health (item 1 in PROMIS-10), n=9,291 
(missing=6.6%)
Excellent (%) 0.4 0.6 0.8 0.8
Very good (%) 3.7 3.7 5.6 3.9
Good (%) 19 19.2 30.1 23.9
Fair (%) 41.8 39.5 44.5 44.2
Poor (%) 35.1 36.9 19 27.3
Emotional problems in last 7 days (item 10 in PROMIS- 
10), n=9291 (missing=6.6%)
Never (%) 5.3 6.2 7.4 7.5
Rarely (%) 15.1 15.2 21.6 19.4
Sometimes (%) 37.4 34.9 42.8 37.5
Often (%) 34.7 35 23.2 28.6
Always (%) 7.4 8.7 5 7.1
Sleep, n=11,709 (missing=4.5%)
Difficulties falling asleep (% often or always) 67.6 65.4 56.9 57.5
Disturbed/poor sleep (% often or always) 80.5 80.2 67.7 70.9
Repeated awakenings (% often or always) 70.2 70.8 59.5 66.2
Early awakenings (% often or always) 62 67.1 55.9 65.8
Fatigue in last 7 days (item 8 in PROMIS-10), n=9291 
(missing=6.6%)
No fatigue (%) 0.8 1.1 1.4 2.3
Mild fatigue (%) 6.5 9.1 13.2 13.3
Moderate fatigue (%) 31.5 35 41.6 39.4
Severe fatigue (%) 43 41.4 33.8 34.8
Very severe fatigue (%) 18.2 13.4 10 10.2
(Continued)
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Table 1 (Continued). 
Variables in the Minimum Core Data Set Baseline (n=12,257) Follow-Up (n=4111)
Women (n=8324; 
67.9%)
Men (n=3933) Women 
(n=2765; 67.3%)
Men (n=1346)
Patient Global Impression of Change, n=3540 
(missing=13.9%)
Very much improved (%) 10.1 8.6
Much improved (%) 17.6 13.8
Minimally improved (%) 20.7 19.7
No change (%) 39.7 42
Minimally worsened (%) 4.5 7.9
Much worsened (%) 4.4 5.4
Very much worsened (%) 3 2.7
Variables in the Additional Data Set Baseline (n=9303) Follow-Up (n=3147)
Women (n=6432) Men (n=2871) Women 
(n=2156)
Men (n=991)
Fear of movement (TSK 17 items: 17–68), M±SD 
(range), higher is worse, n=8392 (missing=9.8%)
39.0±7.8 (17–67) 42.1±8.3 (17–68)
Pain catastrophizing (PCS: 0–52), M±SD (range), higher 
is worse, n=8768 (missing=5.8%)
25.8±11.1 (0–52) 27.5±11.3 (0–52) 18.3±11.4 (0–52) 20.8±12.0 (0–52)
Depression (PHQ9: 0–27), M±SD (range), higher is 
worse, n=8628 (missing=7.3%)
10.5±5.5 (0–27) 10.4±5.9 (0–27) 8.8±5.5 (0–27) 9.5±5.9 (0–27)
Anxiety (GAD7: 0–21), M±SD (range), higher is worse, 
n=8594 (missing=7.2%)
6.0±4.9 (0–21) 6.3±5.3 (0–21)
Stress (PSS 10 items: 0–40), M±SD (range), higher is 
worse, n=8710 (missing=6.4%)
19.1±6.9 (0–40) 19.0±7.3 (0–40)
Disability (PDI 5 items: 0–50), M±SD (range), higher is 
worse, n=8868 (missing=4.7%)
34.9±9.5 (0–50) 35.4±10.1 (0–50) 30.5±10.8 (0–50) 31.7±11.1 (0–50)
Accept (CPAQ 8 items: 0–48), M±SD (range, higher is 
better, n=8600 (missing=7.6%)
21.8±8.5 (0–48) 19.5±9.1 (0–48) 23.1±8.1 (0–47) 20.3±9.0 (0–48)
Self-efficacy (PSEQ 2 items: 0–12), M±SD (range), 
higher is better, n=8509 (missing=8.6%)
5.9±3.2 (0–12) 5.3±3.3 (0–12) 6.4±3.3 (0–12) 5.6±3.3 (0–10)
Self-perceived general health (0–100)#, M±SD (range), 
higher is better n=8639 (missing=7.2%)
45.4±21.6 (0–100) 42.3±22.4 (0–100) 54.0±22.6 (0–100) 48.4±23.7 (0–100)
Memory and/or concentration deficit, n=8832 
(missing=5.1%)
None (%) 8 12.5
Mild (%) 20.5 24.2
Moderate (%) 41.9 39.2
Severe (%) 29.6 24.1
Treatments tried for current pain condition prior to 
referral, n=8327 (missing=10.5%)
Acupuncture (%) 58 54.2
Chiropractor/osteopath (%) 56.4 56.7
Exercise (%) 90.3 88
Massage (%) 75 68.8
Mindfulness (%) 45.8 29.2
Relaxation (%) 54.7 42.5
Surgery (%) 43 48.3
(Continued)
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Characteristics at Follow-Up
In total, 10,452 patients were registered in PainData as hav-
ing completed treatment in a public or private interdisciplin-
ary pain center in Denmark between January 1st 2018 and 
December 31st 2020. The follow-up questionnaire comple-
tion rate was 41.5% (n=4,341) of all completed patients. The 
consent rate for use of personal questionnaire data for quality 
assurance and research use among completers of the follow- 
up questionnaire was 94.4% (n=4,111). Characteristics of the 
population at follow-up in the interdisciplinary pain centers/ 
clinics are shown in Table 1 for women and for men, and the 
responses to the value-based healthcare questions at follow- 
up are shown in Table 3.
Impression of Change
Individuals at follow-up had improved scores compared with 
baseline scores for all domains, and one out of four indivi-
duals reported being very much improved or much improved 
after treatment. The proportion of individuals using analge-
sics at follow-up was reduced, and, specifically, the propor-
tion of opioid users was decreased at follow-up compared 
with baseline. For the patients who started and completed 
treatment within the period 2018–2020, who completed both 
questionnaires and gave data consent, the mean treatment 
duration was 217±170 days (range 0–1043 days). The 
within-group changes in outcomes were mostly of small to 
moderate effect sizes, with the largest effect observed for 
pain catastrophizing (Table 4).
Value-Based Healthcare Items
The achievements that most individuals reported (scores 
from “to a moderate degree” to “to a very great degree”) 
were “gained knowledge about pain, emotions and mood” 
(66.5%), “had become better at accepting life with chronic 
pain” (63.1%), and “improved activity pacing” (60.6%).
The achievements that fewest individuals reported 
(scores from: “to a moderate degree” to “to a very great 
degree”) were “help with work and income” (24.4%), 
“helped to sleep better” (38.1%), and “recieved help to 
learn pain coping strategies” (49.2%) (Table 3).
Comparison of Follow-Up Questionnaire 
Completers and Non-Completers
Individuals who completed the follow-up questionnaire 
were not different regarding sex, pain duration, pain inten-
sity, pain-related disability, opioid use, and fear of move-
ment scores compared with non-responders (Table 5). 
However, individuals who did not complete the follow- 
up questionnaire were on average 3 years younger, with 
higher scores on pain catastrophizing, stress, anxiety and 
depression, and with lower scores on pain acceptance, self- 
efficacy, and physical and mental health at baseline.
Discussion
In this paper, we have described the aims and content of 
the clinical PainData registry as well as the participant 
recruitment/response rate across public and private inter-
disciplinary pain centers in Denmark. We have also 
reported socio-demographics, pain characteristics, quality 
of life, and treatment values before and after treatment in 
a large sample of individuals with high-impact chronic 
pain referred to public and private interdisciplinary pain 
centers in Denmark. A higher proportion of women 
Table 1 (Continued). 
Variables in the Minimum Core Data Set Baseline (n=12,257) Follow-Up (n=4111)
Women (n=8324; 
67.9%)
Men (n=3933) Women 
(n=2765; 67.3%)
Men (n=1346)
Reflexology (%) 31.6 22.6
Tried 4 or more treatments (%) 58.4 51.5
Exposed to traumatic event (%), n=8747 
(missing=6.0%)
59.4 57.6
Pain related to trauma (%, only asked to patients 
reporting exposure to traumatic event), n=5146
38.3 50.6
Insurance claim (%), n=8742 (missing=6.1%) 16.7 24.9
Notes: *Assessed using one-item psychosocial screening questions validated in this setting for each construct; #assessed using the EuroQoL health thermometer. 
Abbreviations: BMI, body mass index; NRS, numerical rating scale; NSAID, non-steroidal anti-inflammatory drug; PROMIS-10, 10-item Patient-Reported Outcomes 
Measurement Information System; TSK, Tampa Scale of Kinesiophobia; PCS, Pain Catastrophizing Scale; PHQ9, 9-item Patient Health Questionnaire; GAD7, 7-item 
Generalized Anxiety Disorder; PSS, Cohen’s Perceived Stress Scale; PDI, Pain Disability Index; CPAQ, Chronic Pain Acceptance Questionnaire; PSEQ, Pain Self-Efficacy 
Questionnaire.
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compared with men attended specialized interdisciplinary 
pain centers in Denmark. Most patients had had pain for 
more than 5 years and one in three patients reported 
chronic widespread pain. The use of opioids was common 
and most patients had tried a number of treatments in 
primary and secondary care settings with an unsatisfactory 
clinical response. Poor sleep, severe fatigue, and memory 
and/or concentration deficits were reported by more than 
60% of patients. The patient group had high scores on pain 
catastrophizing, fear of movement, and pain-related dis-
ability, whereas scores on pain acceptance and self- 
efficacy were low. Scores on depression and anxiety 
Table 2 Baseline Characteristics Presented with Cumulative Percentiles for Individuals Who Had an Initial Consultation in a Public or 
Private Interdisciplinary Pain Center in Denmark from 2018 to 2020.
Variables in the Minimum 
Core Data Set
Women (n=8324) Men (n=3933)
5th 10th 25th 50th 75th 90th 95th 5th 10th 25th 50th 75th 90th 95th
Age 25 30 39 49 58 70 75 28 32 42 52 62 71 76
Weight 156 158 163 167 171 175 178 168 171 175 180 184 189 192
Height 53 57 65 76 89 104 115 65 70 79 90 102 115 125
BMI 19.4 20.7 23.3 27.3 31.9 36.7 40.1 20.9 22.4 24.7 27.7 31.4 35.3 38.0
Pain duration (years) 0.9 1.3 2.7 6.7 14.4 25.0 31.7 0.8 1.1 2.2 5.3 13.0 24.0 31.0
Peak pain intensity last 24 
hours (NRS: 0–10)
5 6 7 8 9 10 10 5 6 7 8 9 10 10
Average pain intensity last 24 
hours (NRS: 0–10)
3 4 5 7 8 9 10 3 4 5 7 8 9 9
Least pain intensity last 24 
hours (NRS: 0–10)
1 2 3 5 6 8 9 1 2 3 5 6 8 9
Average pain intensity last 7 
days (NRS: 0–10)
2 2 2 5 8 9 9 2 2 2 5 8 9 9
Pain areas (0–71) 3 5 10 20 34 49 58 2 4 7 14 24 36 45
Painful body regions (0–7) 1 2 3 5 7 7 7 1 1 2 4 6 7 7
Analgesic pain relief (%) 0 10 20 40 50 70 80 0 10 20 40 50 70 80
Stress (NRS: 0–10) 0 0 2 5 8 9 10 0 0 2 5 7 9 10
Pain catastrophizing (NRS: 
0–10)
2 3 5 8 9 10 10 2 3 5 8 9 10 10
Fear of movement (NRS: 0–10) 0 0 2 5 8 10 10 0 0 3 6 9 10 10
PROMIS-10 Physical Health 23.5 26.7 29.6 32.4 37.4 39.8 42.3 23.5 26.7 29.6 34.9 37.4 42.3 44.9
PROMIS-10 Mental Health 25.1 28.4 33.8 38.8 43.5 48.3 50.8 25.1 28.4 33.8 36.3 43.5 48.3 50.8
Variables in the Additional 
Larger Data Set
Women (n=6432) Men (n=2871)
5th 10th 25th 50th 75th 90th 95th 5th 10th 25th 50th 75th 90th 95th
Fear of movement (TSK 17 
items: 17–68)
26 29 34 39 44 49 52 28 32 37 42 47 53 56
Pain catastrophizing (PCS: 
0–52)
8 11 18 26 34 41 45 9 13 19 28 36 43 46
Depression (PHQ9: 0–27) 2 4 6 10 14 18 21 2 3 6 10 14 19 22
Anxiety (GAD7: 0–21) 0 0 2 5 9 14 16 0 0 2 5 9 14 17
Stress (PSS 10 items: 0–40) 8 10 14 19 24 28 31 7 9 14 19 24 28 31
Disability (PDI 5 items: 0–50) 17 22 29 36 42 46 48 15 21 30 37 43 47 49
Accept (CPAQ 8 items: 0–48) 7 11 16 22 27 33 36 4 8 13 20 25 31 35
Self-efficacy (PSEQ 2 items: 
0–12)
0 2 4 6 8 10 11 0 1 3 5 8 10 11
Self-perceived general health 
(EQ5D-VAS: 0–100)
10 18 30 45 60 75 80 9 14 25 40 60 75 80
Abbreviations: BMI, body mass index; NRS, numerical rating scale; PROMIS-10, 10-item Patient-Reported Outcomes Measurement Information System; TSK, Tampa Scale 
of Kinesiophobia; PCS, Pain Catastrophizing Scale; PHQ9, 9-item Patient Health Questionnaire; GAD7, 7-item Generalized Anxiety Disorder; PSS, Cohen’s Perceived Stress 
Scale; PDI, Pain Disability Index; CPAQ, Chronic Pain Acceptance Questionnaire; PSEQ, Pain Self-Efficacy Questionnaire; EQ5D, EuroQol 5 Dimensions; VAS, visual analogue 
scale.
https://doi.org/10.2147/JPR.S306504                                                                                                                                                                                                                                   
DovePress                                                                                                                                                               
Journal of Pain Research 2021:14 1224
Vaegter et al                                                                                                                                                          Dovepress
Table 3 Responses to Value-Based Healthcare Questions from Individuals Who Had an Initial Consultation (Baseline) and Individuals 
Who Completed Treatment (Follow-Up) in a Public or Private Interdisciplinary Pain Center in Denmark from 2018 to 2020.
Baseline (n=9045) Follow-Up (n= 2819)
Items and 
Questions
Response Options Women Men Items and 
Questions






Pain acceptance Pain acceptance
‘Is it important for 
you to get better at 
accepting your life 
with chronic pain?’
Not at all (%) 6.9 9.6 ‘Have you become 
better at accepting 
your life with 
chronic pain?’
Not at all (%) 13.6 20.5
To a slight degree (%) 10.6 12.1 To a slight degree (%) 17.2 24.3
To a moderate degree (%) 21.3 25.2 To a moderate degree (%) 43.1 35.9
To a great degree (%) 30.1 29.7 To a great degree (%) 22.4 15.5
To a very great degree (%) 31.1 23.4 To a very great degree (%) 3.7 3.8
Social activities Social activities
‘Is it important for 
you to be able to be 
with family and 
friends and 
participate in other 
social events?’
Not at all (%) 1.6 2.4 ‘Have you become 
better at being with 
family and friends 
and attending other 
social events?’
Not at all (%) 22 29.1
To a slight degree (%) 3.7 5.4 To a slight degree (%) 22.9 27.5
To a moderate degree (%) 11.3 13.7 To a moderate degree (%) 40.3 31.6
To a great degree (%) 30.2 35.2 To a great degree (%) 12.4 9.1
To a very great degree (%) 53.2 43.4 To a very great degree (%) 2.4 2.7
Sleep Sleep
‘Is it important for 
you to get help to 
sleep better?’
Not at all (%) 10.7 11.6 ‘Have you been 
helped to sleep 
better?’
Not at all (%) 39.4 45
To a slight degree (%) 10.1 9 To a slight degree (%) 19 22.5
To a moderate degree (%) 16.7 16 To a moderate degree (%) 23.9 19.9
To a great degree (%) 24.6 25.6 To a great degree (%) 13.8 10.5
To a very great degree (%) 37.9 37.7 To a very great degree (%) 4 2.1
Analgesics Analgesics
‘Is it important for 
you to try to relieve 
your pain by trying 
different painkillers?’
Not at all (%) 6.6 6.2 ‘Have you been 
helped to try to 
relieve your pain by 
trying different 
painkillers?’
Not at all (%) 25.7 24.5
To a slight degree (%) 11.1 10.1 To a slight degree (%) 15.4 15.7
To a moderate degree (%) 23.2 21.3 To a moderate degree (%) 24.4 27.5
To a great degree (%) 27.1 28 To a great degree (%) 24.2 23.7





‘Is it important for 
you to get help to 
cope with your pain 
with e.g. physical and 
mental exercises and 
techniques?’
Not at all (%) 6 7.2 ‘Have you received 
help to cope with 
your pain with e.g. 
physical and mental 
exercises and 
techniques?’
Not at all (%) 26.6 32.1
To a slight degree (%) 9.2 10.9 To a slight degree (%) 19.4 22.2
To a moderate degree (%) 19.4 21.8 To a moderate degree (%) 31.5 28.2
To a great degree (%) 30.1 30 To a great degree (%) 19 14.4
To a very great degree (%) 35.4 30.2 To a very great degree (%) 3.4 3.2
Mood and worries Mood and 
worries
‘Is it important for 
you to gain 
knowledge about 
how your pain can 
affect your emotions 
and your mood?’
Not at all (%) 11.3 10.2 ‘Have you gained 
knowledge about 
how your pain can 
affect your 
emotions and your 
mood?’
Not at all (%) 16.5 21.9
To a slight degree (%) 13.7 13 To a slight degree (%) 13.5 16.9
To a moderate degree (%) 21.6 23 To a moderate degree (%) 27.5 32.2
To a great degree (%) 25 27.2 To a great degree (%) 31.5 21.6
To a very great degree (%) 28.4 26.6 To a very great degree (%) 11 7.5
(Continued)
Journal of Pain Research 2021:14                                                                                                     https://doi.org/10.2147/JPR.S306504                                                                                                                                                                                                                       
DovePress                                                                                                                       
1225
Dovepress                                                                                                                                                         Vaegter et al
were low to moderate, indicating that patients were more 
distressed than depressed. Physical and mental health were 
rated as poor and fair, respectively. One in four patients 
reported being very much improved or much improved 
after treatment. Items commonly reported after treatment 
were increased knowledge about pain, emotions and mood 
(66.5%), better at accepting life with chronic pain (63.1%), 
and improved activity pacing (60.6%).
The socio-demographics (age, sex, work status) and pain 
characteristics (duration, patient-reported cause, localization, 
intensity, use of analgesics, mood and cognitions) of the 
PainData sample in Denmark are in line with the character-
istics of populations with high-impact chronic pain in, for 
example, Australia and New Zealand12 and Sweden.13 In 
addition, the improvements reported after interdisciplinary 
pain rehabilitation in Denmark are of similar magnitude to 
those reported in the EPOCC registry (Australia and New 
Zealand)12 and the SQRP registry (Sweden).13 Among the 
patients referred to specialized interdisciplinary pain 
treatment in Denmark, the proportion of women was larger 
than the proportion of men. Some differences in 
PROs between women and men were noted. Women 
reported a higher number of painful body areas, whereas 
men reported higher scores on fear of movement and pain 
catastrophizing, and lower scores on acceptance and self- 
perceived general health. In addition, a higher proportion of 
men reported opioid use and pain related to trauma.
To date, several research projects26,29–33 have used data 
from the PainData registry, resulting in a number of publica-
tions, with more in press or under preparation. These projects 
have included collaborations between researchers from 
Denmark, Australia, Germany, and Ireland. The functionality 
of the registry allows easy implementation of additional 
questions and questionnaires for future research projects.
Strengths and Limitations
The PainData registry has a number of strengths. One 
strength is that the population is a consecutive cohort of 
Table 3 (Continued). 
Baseline (n=9045) Follow-Up (n= 2819)
Items and 
Questions
Response Options Women Men Items and 
Questions







‘Is it important for 
you to be able to tell 
your loved ones and 
others what it is like 
to live with chronic 
pain?’
Not at all (%) 11.8 15.3 ‘Have you become 
better at being able 
to tell your loved 
ones and others 
what it is like to 
live with chronic 
pain?’
Not at all (%) 20 24.9
To a slight degree (%) 17.9 17.6 To a slight degree (%) 24.2 21.4
To a moderate degree (%) 25.9 25.4 To a moderate degree (%) 32.4 32.1
To a great degree (%) 22.4 23.9 To a great degree (%) 18.8 17.4
To a very great degree (%) 22 17.8 To a very great degree (%) 4.5 4.2
Work and income Work and 
income
‘Is it important for 
you to get help with 
what you can do in 
relation to your 
finances and your 
opportunities on the 
labor market?’
Not at all (%) 30.2 30.1 ‘Have you received 
help with what you 
can do in relation 




Not at all (%) 59.6 64.5
To a slight degree (%) 11.3 12.2 To a slight degree (%) 13.1 12.6
To a moderate degree (%) 14.2 16.5 To a moderate degree (%) 15.5 14
To a great degree (%) 17.2 18.9 To a great degree (%) 8.3 6.4
To a very great degree (%) 27.1 22.3 To a very great degree (%) 3.6 2.5
Activity pacing Activity pacing
‘Is it important for 
you to achieve an 
appropriate balance 
between activity and 
rest?’ 
Not at all (%) 3.3 4.6 ‘Have you become 




Not at all (%) 13.8 18.4
To a slight degree (%) 6 8.3 To a slight degree (%) 21.6 27
To a moderate degree (%) 19.2 26.1 To a moderate degree (%) 38.9 35.3
To a great degree (%) 33.1 34.3 To a great degree (%) 21.1 16
To a very great degree (%) 38.4 26.7 To a very great degree (%) 4.7 3.3
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all patients referred to the public and private interdisci-
plinary pain centers/clinics in Denmark, which improves 
its generalizability. Another strength is the recording of 
each patient’s central person registration number, which 
facilitates data linkage with other Danish registries. In the 
context of the Danish healthcare system, population-based 
registers include those containing data on primary and 
secondary healthcare utilization, hospital diagnoses, pre-
scription drugs, social conditions, work participation, and 
public welfare support.14,15
The registry also has a number of weaknesses. First, less 
than half the patients complete follow-up questionnaires. 
This may reflect that the registry is not a discrete research 
project where only people who agree to full participation are 
included. It may also reflect that the main focus within the 
interdisciplinary pain centers/clinics so far has been on com-
pletion of the baseline questionnaire, as an integrated part of 
clinical practice and used during the initial consultation with 
the patient. Several measures to improve follow-up partici-
pation are currently being implemented, including providing 
automated reminders in the official e-Boks to those who had 
not completed the questionnaire, and a reduction in the 
number of questions at follow-up to reduce the response 
burden. Despite this, the follow-up completion rate may 
also remain a weakness of the registry in the future. 
Routine data collection as part of clinical practice differs 
from collecting data to answer a specific research question, 
as it involves a trade-off between using detailed and validated 
questionnaires and being able to cover a number of poten-
tially important clinical aspects of chronic pain. For example, 
in the PainData registry minimum core data set, one-item 
screening questions to assess fear of movement, pain cata-
strophizing, and stress are used to reduce the length of the 
survey and responder burden. Although these screening 
questions have known concurrent validity in this clinical 
setting,26 relative to full reference validated standard ques-
tionnaires, their test–retest reliability, relative responsive-
ness, and prognostic value are still unknown. The inclusion 
of the full validated questionnaires in some of the pain 
centers will allow further investigation of this in the future. 
Other limitations may be the use of online questionnaires, as 
some patients may have limited access to a computer, and 
Table 4 Patient-Reported Outcome Measures at Baseline and Follow-Up for Patients Who Started and Completed Treatment Within 
the Period 2018–2020, Who Completed Both Questionnaires and Provided Data consent.
Baseline Characteristics Baseline Follow-Up Difference Cohen’s 
d Effect Size
Mean ± SD (95% CI)
Peak pain intensity (NRS: 0–10), higher is worse, M±SD, n=2661 7.8±1.6 6.9±2.1 0.84±2.0 (0.77 to 0.92) 0.42
Average pain intensity (NRS: 0–10), higher is worse, M±SD, 
n=2658
6.4±1.8 5.8±2.1 0.68±2.0 (0.60 to 0.75) 0.34
Least pain intensity (NRS: 0–10), higher is worse, M±SD, n=2639 4.7±2.3 4.3±2.4 0.43±2.3 (0.34 to 0.51) 0.19
Analgesic use (%), n=2564 90.5 80.5 –
Opioid use (%), n=2564 42.7 26.8 –
Stress (NRS: 0–10)*, higher is worse, M±SD, n=2470 4.5±3.2 4.2±3.0 0.28±2.7 (0.17 to 0.38) 0.10
Pain catastrophizing (NRS: 0–10)*, higher is worse, M±SD, n=2460 6.9±2.8 5.5±3.0 1.33±2.8 (1.22 to 1.44) 0.48
Fear of movement (NRS: 0–10)*, higher is worse, M±SD, 
n=2366
5.3±3.4 4.3±3.5 1.0±3.4 (0.86 to 1.1) 0.29
PROMIS-10 Physical Health, higher is better, M±SD, n=1780 35.4±5.7 35.2±6.6 0.23±5.9 (−0.04 to 0.51) 0.04
PROMIS-10 Mental Health, higher is better, M±SD, n=1786 38.9±7.7 40.4±8.1 −1.50±6.9 (−1.83 to −1.18) 0.22
Pain catastrophizing (PCS: 0–52), higher is worse, M±SD, n=1660 25.9±11.1 19.4±11.9 6.48±9.3 (6.03 to 6.93) 0.70
Depression (PHQ9: 0–27), higher is worse, M±SD, n=1654 10.0±5.6 9.0±5.7 1.00±4.9 (0.76 to 1.24) 0.20
Disability (PDI 5 items: 0–50), higher is worse, M±SD, n=1736 34.9±9.7 30.8±11.0 4.09±9.3 (3.65 to 4.52) 0.44
Accept (CPAQ 8 items: 0–48), higher is better, M±SD, n=1681 21.4±8.6 22.3±8.5 −0.89±7.54 (−1.26 to −0.53) 0.12
Self-efficacy (PSEQ 2 items: 0–12), higher is better, M ±SD, n=1635 6.0±3.2 6.2±3.4 −0.17±2.87 (−0.31 to −0.04) 0.06
Self-perceived general health (EQ5D-VAS: 0–100), higher is 
better#, M±SD, n=1681
46.8±22.0 50.7±23.2 −3.86±23.9 (−5.0 to −2.71) 0.16
Notes: *Assessed using one-item or two-item psychosocial screening questions and thresholds validated in this setting for each construct; #assessed using the EuroQoL 
health 0–100 VAS thermometer. 
Abbreviations: NRS, numerical rating scale; PROMIS-10, 10-item Patient-Reported Outcomes Measurement Information System; PCS, Pain Catastrophizing Scale; PHQ9, 9 
items Patient Health Questionnaire; PDI, Pain Disability Index; CPAQ, Chronic Pain Acceptance Questionnaire; PSEQ, Pain Self-Efficacy Questionnaire; EQ5D, EuroQol 5 
Dimensions; VAS, visual analogue scale.
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some elderly patients may have difficulties in handling 
a computer. However, according to the Danish Agency of 
Digitization, almost 93% of the Danish population above 15 
years of age uses digital mail, although the proportion of 
citizens not using digital mail is larger among individuals 
above 65 years of age,34 and the proportion of citizens not 
using digital mail among this group of severely affected 
patients may be even larger.
Conclusion
The PainData registry contains PRO data from a large and 
comprehensive observational cohort of individuals attend-
ing public and private interdisciplinary pain centers in 
Denmark for the assessment and treatment of high- 
impact chronic pain. The registry contains detailed base-
line and outcomes data on a broad range of biopsychoso-
cial factors, and new data (eg, new questionnaires for 
clinical or research purposes) can be collected in the 
future. These data are in line with the characteristics of 
populations with high-impact chronic pain in other 
countries and can be linked to the Danish population- 
based registries. Collaborations with other researchers are 
welcome.
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